In order to address data collection and study design needs throughout the RPCI catchment area and beyond, the Survey Research and Data Acquisition Resource (SRDAR) provides access to large population-based data in the primary service area and in other areas as scientific needs may dictate. Specific SRDAR services include telephone, in-person, electronic, and forms-based surveying;survey and study design and development;measure validation;investigator and staff training;project development and consultation;and national multi-center project collaboration and conduct. This Resource provides broad-based expertise to facilitate transdisciplinary research among population science and clinical investigators. Having this in-house capability allows for centralized data collection with built-in checks and balances of study logistics, at a significant cost savings over using external service providers. SRDAR has experience with multi-Center and multi-organizational projects at the national and international levels. SRDAR fosters collaboration across other NCI and peer-reviewed mechanisms, including program projects, SPOREs, and NCTN clinical research. For example, in one NCI-funded study to increase website traffic to the website offered by the New York State Smoker's Quitline (NYSSQL), SRDAR assisted 560,000 participants in 2012. First priority for use is given to peer-reviewed funded RPCI CCSG members;second priority to non-peer review funded CCSG members;third priority to non-members and academic collaborators;and last priority to external users. During the reporting period, the SRDAR Shared Resource has served 5 members from 2 research programs, with 16% utilization by CCSG members with peer reviewed funding. SRDAR has also assisted other national or collaborative projects including those with the Hollings Cancer Center (3P01GA138389-05S1), University of Michigan Cancer Center (5P50CA101451-10), Yale Cancer Center (R01CA068427-13) and Sidney Kimmel Comprehensive Cancer Center. SRDAR currently has 43 employees including 29 trained data collection staff. The CCSG support provides 3% of the overall proposed budget.
SRDAR serves as a centralized resource at RPCI that specializes in facilitating, collecting, and improving the quality of survey research data from clinical and population-based studies. Having this in-house capability impacts RPCI studies throughout the 8-county catchment area, and enables conduct of large epidemiologic, education, and dissemination studies.
|Ling, Xiang; Wu, Wenjie; Fan, Chuandong et al. (2018) An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer. J Exp Clin Cancer Res 37:240|
|Chung, Sejin; Vail, Paris J; Witkiewicz, Agnieszka K et al. (2018) Coordinately targeting cell cycle checkpoint functions in integrated models of pancreatic cancer. Clin Cancer Res :|
|Eng, Diana G; Kaverina, Natalya V; Schneider, Remington R S et al. (2018) Detection of renin lineage cell transdifferentiation to podocytes in the kidney glomerulus with dual lineage tracing. Kidney Int 93:1240-1246|
|Hsu, Alice H; Lum, Michelle A; Shim, Kang-Sup et al. (2018) Crosstalk between PKC? and PI3K/AKT Signaling Is Tumor Suppressive in the Endometrium. Cell Rep 24:655-669|
|Sandlesh, Poorva; Juang, Thierry; Safina, Alfiya et al. (2018) Uncovering the fine print of the CreERT2-LoxP system while generating a conditional knockout mouse model of Ssrp1 gene. PLoS One 13:e0199785|
|Mohammadpour, Hemn; O'Neil, Rachel; Qiu, Jingxin et al. (2018) Blockade of Host ?2-Adrenergic Receptor Enhances Graft-versus-Tumor Effect through Modulating APCs. J Immunol 200:2479-2488|
|Damayanti, Nur P; Budka, Justin A; Khella, Heba W Z et al. (2018) Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma. Clin Cancer Res 24:5977-5989|
|Mayor, Paul; Starbuck, Kristen; Zsiros, Emese (2018) Adoptive cell transfer using autologous tumor infiltrating lymphocytes in gynecologic malignancies. Gynecol Oncol 150:361-369|
|Zhang, Dingxiao; Zhao, Shuhong; Li, Xinyun et al. (2018) Prostate Luminal Progenitor Cells in Development and Cancer. Trends Cancer 4:769-783|
|Hong, Chi-Chen; Sucheston-Campbell, Lara E; Liu, Song et al. (2018) Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium. Cancer Epidemiol Biomarkers Prev 27:321-330|
Showing the most recent 10 out of 1555 publications